The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases - EP3212200

The patent EP3212200 was granted to Centre National DE LA Recherche Scientifique on Jan 20, 2021. The application was originally filed on Oct 30, 2015 under application number EP15798211A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3212200

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Application Number
EP15798211A
Filing Date
Oct 30, 2015
Status
Granted And Under Opposition
Dec 18, 2020
Publication Date
Jan 20, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SCHLICHJun 18, 2021SCHLICHADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTDE4307883
INTERNATIONAL-SEARCH-REPORTKR20100073528
INTERNATIONAL-SEARCH-REPORTUS2015018297
INTERNATIONAL-SEARCH-REPORTWO0050043
INTERNATIONAL-SEARCH-REPORTWO2009153009
OPPOSITIONUS2014113952
OPPOSITIONUS2015018297
OPPOSITIONWO2009153009
OPPOSITIONWO2016067265

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents